nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—Hyponatraemia—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Atropine—Osteoarthritis—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Atropine—Feeling abnormal—Dactinomycin—testicular cancer	0.00149	0.00149	CcSEcCtD
Atropine—Nausea—Chlorambucil—testicular cancer	0.00148	0.00148	CcSEcCtD
Atropine—Anxiety—Cisplatin—testicular cancer	0.00148	0.00148	CcSEcCtD
Atropine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00147	0.00147	CcSEcCtD
Atropine—Dyspnoea—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Atropine—Somnolence—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Atropine—Vomiting—Vinblastine—testicular cancer	0.00146	0.00146	CcSEcCtD
Atropine—Vertigo—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Atropine—Headache—Vinblastine—testicular cancer	0.00143	0.00143	CcSEcCtD
Atropine—Body temperature increased—Dactinomycin—testicular cancer	0.00143	0.00143	CcSEcCtD
Atropine—Abdominal pain—Dactinomycin—testicular cancer	0.00143	0.00143	CcSEcCtD
Atropine—Fatigue—Ifosfamide—testicular cancer	0.00143	0.00143	CcSEcCtD
Atropine—Oedema—Cisplatin—testicular cancer	0.00142	0.00142	CcSEcCtD
Atropine—Anaphylactic shock—Cisplatin—testicular cancer	0.00142	0.00142	CcSEcCtD
Atropine—Hypersensitivity—Bleomycin—testicular cancer	0.00142	0.00142	CcSEcCtD
Atropine—Cardiac arrest—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Atropine—Pain—Ifosfamide—testicular cancer	0.00141	0.00141	CcSEcCtD
Atropine—Constipation—Ifosfamide—testicular cancer	0.00141	0.00141	CcSEcCtD
Atropine—Hypoglycaemia—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Atropine—Loss of consciousness—Etoposide—testicular cancer	0.00141	0.00141	CcSEcCtD
Atropine—Lethargy—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Atropine—Ataxia—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Atropine—Tachycardia—Cisplatin—testicular cancer	0.00139	0.00139	CcSEcCtD
Atropine—Asthenia—Bleomycin—testicular cancer	0.00139	0.00139	CcSEcCtD
Atropine—Convulsion—Etoposide—testicular cancer	0.00139	0.00139	CcSEcCtD
Atropine—Dehydration—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Atropine—Hyponatraemia—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Atropine—Osteoarthritis—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Atropine—Hyperhidrosis—Cisplatin—testicular cancer	0.00138	0.00138	CcSEcCtD
Atropine—Pruritus—Bleomycin—testicular cancer	0.00137	0.00137	CcSEcCtD
Atropine—Dry skin—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Atropine—Feeling abnormal—Ifosfamide—testicular cancer	0.00136	0.00136	CcSEcCtD
Atropine—Chest pain—Etoposide—testicular cancer	0.00136	0.00136	CcSEcCtD
Atropine—Nausea—Vinblastine—testicular cancer	0.00136	0.00136	CcSEcCtD
Atropine—Hypokalaemia—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Atropine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00135	0.00135	CcSEcCtD
Atropine—Hypotension—Cisplatin—testicular cancer	0.00133	0.00133	CcSEcCtD
Atropine—Hypersensitivity—Dactinomycin—testicular cancer	0.00133	0.00133	CcSEcCtD
Atropine—Confusional state—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Atropine—Urticaria—Ifosfamide—testicular cancer	0.00131	0.00131	CcSEcCtD
Atropine—Cardiac arrest—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Atropine—Abdominal pain—Ifosfamide—testicular cancer	0.00131	0.00131	CcSEcCtD
Atropine—Body temperature increased—Ifosfamide—testicular cancer	0.00131	0.00131	CcSEcCtD
Atropine—Anaphylactic shock—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Atropine—Abdominal distension—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Atropine—Ataxia—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Atropine—Asthenia—Dactinomycin—testicular cancer	0.00129	0.00129	CcSEcCtD
Atropine—Dysphagia—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Atropine—Dysuria—Methotrexate—testicular cancer	0.00129	0.00129	CcSEcCtD
Atropine—Dehydration—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Atropine—Tachycardia—Etoposide—testicular cancer	0.00127	0.00127	CcSEcCtD
Atropine—Dyspnoea—Cisplatin—testicular cancer	0.00127	0.00127	CcSEcCtD
Atropine—Erectile dysfunction—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Atropine—Dry skin—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Atropine—Hyperhidrosis—Etoposide—testicular cancer	0.00126	0.00126	CcSEcCtD
Atropine—Hypokalaemia—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Atropine—Angina pectoris—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Atropine—Diarrhoea—Dactinomycin—testicular cancer	0.00123	0.00123	CcSEcCtD
Atropine—Vomiting—Bleomycin—testicular cancer	0.00123	0.00123	CcSEcCtD
Atropine—Drowsiness—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Atropine—Depression—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Atropine—Hypotension—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Atropine—Rash—Bleomycin—testicular cancer	0.00122	0.00122	CcSEcCtD
Atropine—Pain—Cisplatin—testicular cancer	0.00122	0.00122	CcSEcCtD
Atropine—Dermatitis—Bleomycin—testicular cancer	0.00122	0.00122	CcSEcCtD
Atropine—Hypersensitivity—Ifosfamide—testicular cancer	0.00122	0.00122	CcSEcCtD
Atropine—Dysuria—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Atropine—Abdominal distension—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Atropine—Conjunctivitis—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Atropine—Dysphagia—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Atropine—Asthenia—Ifosfamide—testicular cancer	0.00119	0.00119	CcSEcCtD
Atropine—Sweating—Methotrexate—testicular cancer	0.00118	0.00118	CcSEcCtD
Atropine—Feeling abnormal—Cisplatin—testicular cancer	0.00117	0.00117	CcSEcCtD
Atropine—Pruritus—Ifosfamide—testicular cancer	0.00117	0.00117	CcSEcCtD
Atropine—Dyspnoea—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Atropine—Hyperglycaemia—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Atropine—Somnolence—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Atropine—Angina pectoris—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Atropine—Nausea—Bleomycin—testicular cancer	0.00115	0.00115	CcSEcCtD
Atropine—Drowsiness—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Atropine—Vomiting—Dactinomycin—testicular cancer	0.00115	0.00115	CcSEcCtD
Atropine—Rash—Dactinomycin—testicular cancer	0.00114	0.00114	CcSEcCtD
Atropine—Diarrhoea—Ifosfamide—testicular cancer	0.00113	0.00113	CcSEcCtD
Atropine—Body temperature increased—Cisplatin—testicular cancer	0.00113	0.00113	CcSEcCtD
Atropine—Fatigue—Etoposide—testicular cancer	0.00113	0.00113	CcSEcCtD
Atropine—Pain—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Atropine—Constipation—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Atropine—Conjunctivitis—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Atropine—Dysuria—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Atropine—Sweating—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Atropine—Dizziness—Ifosfamide—testicular cancer	0.00109	0.00109	CcSEcCtD
Atropine—Feeling abnormal—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Atropine—Hyperglycaemia—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Atropine—Nausea—Dactinomycin—testicular cancer	0.00107	0.00107	CcSEcCtD
Atropine—Gastrointestinal pain—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Atropine—Drowsiness—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Atropine—Vomiting—Ifosfamide—testicular cancer	0.00105	0.00105	CcSEcCtD
Atropine—Hypersensitivity—Cisplatin—testicular cancer	0.00105	0.00105	CcSEcCtD
Atropine—Bradycardia—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Atropine—Rash—Ifosfamide—testicular cancer	0.00104	0.00104	CcSEcCtD
Atropine—Dermatitis—Ifosfamide—testicular cancer	0.00104	0.00104	CcSEcCtD
Atropine—Urticaria—Etoposide—testicular cancer	0.00104	0.00104	CcSEcCtD
Atropine—Abdominal pain—Etoposide—testicular cancer	0.00103	0.00103	CcSEcCtD
Atropine—Body temperature increased—Etoposide—testicular cancer	0.00103	0.00103	CcSEcCtD
Atropine—Conjunctivitis—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Atropine—Asthenia—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Atropine—Sweating—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Atropine—Nausea—Ifosfamide—testicular cancer	0.000982	0.000982	CcSEcCtD
Atropine—Diarrhoea—Cisplatin—testicular cancer	0.000975	0.000975	CcSEcCtD
Atropine—Bradycardia—Doxorubicin—testicular cancer	0.00097	0.00097	CcSEcCtD
Atropine—Mental disorder—Methotrexate—testicular cancer	0.000964	0.000964	CcSEcCtD
Atropine—Hypersensitivity—Etoposide—testicular cancer	0.000962	0.000962	CcSEcCtD
Atropine—Erythema—Methotrexate—testicular cancer	0.000958	0.000958	CcSEcCtD
Atropine—Flushing—Epirubicin—testicular cancer	0.000956	0.000956	CcSEcCtD
Atropine—Dysgeusia—Methotrexate—testicular cancer	0.000938	0.000938	CcSEcCtD
Atropine—Asthenia—Etoposide—testicular cancer	0.000937	0.000937	CcSEcCtD
Atropine—Pruritus—Etoposide—testicular cancer	0.000924	0.000924	CcSEcCtD
Atropine—Arrhythmia—Epirubicin—testicular cancer	0.00092	0.00092	CcSEcCtD
Atropine—Vomiting—Cisplatin—testicular cancer	0.000906	0.000906	CcSEcCtD
Atropine—Vision blurred—Methotrexate—testicular cancer	0.000903	0.000903	CcSEcCtD
Atropine—Mental disorder—Epirubicin—testicular cancer	0.000902	0.000902	CcSEcCtD
Atropine—Rash—Cisplatin—testicular cancer	0.000898	0.000898	CcSEcCtD
Atropine—Dermatitis—Cisplatin—testicular cancer	0.000898	0.000898	CcSEcCtD
Atropine—Erythema—Epirubicin—testicular cancer	0.000897	0.000897	CcSEcCtD
Atropine—Diarrhoea—Etoposide—testicular cancer	0.000893	0.000893	CcSEcCtD
Atropine—Flushing—Doxorubicin—testicular cancer	0.000884	0.000884	CcSEcCtD
Atropine—Tension—Epirubicin—testicular cancer	0.00088	0.00088	CcSEcCtD
Atropine—Dysgeusia—Epirubicin—testicular cancer	0.000878	0.000878	CcSEcCtD
Atropine—Nervousness—Epirubicin—testicular cancer	0.000871	0.000871	CcSEcCtD
Atropine—Dizziness—Etoposide—testicular cancer	0.000863	0.000863	CcSEcCtD
Atropine—Vertigo—Methotrexate—testicular cancer	0.000861	0.000861	CcSEcCtD
Atropine—Arrhythmia—Doxorubicin—testicular cancer	0.000851	0.000851	CcSEcCtD
Atropine—Nausea—Cisplatin—testicular cancer	0.000846	0.000846	CcSEcCtD
Atropine—Vision blurred—Epirubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Atropine—Mental disorder—Doxorubicin—testicular cancer	0.000835	0.000835	CcSEcCtD
Atropine—Convulsion—Methotrexate—testicular cancer	0.00083	0.00083	CcSEcCtD
Atropine—Vomiting—Etoposide—testicular cancer	0.00083	0.00083	CcSEcCtD
Atropine—Erythema—Doxorubicin—testicular cancer	0.00083	0.00083	CcSEcCtD
Atropine—Agitation—Epirubicin—testicular cancer	0.000824	0.000824	CcSEcCtD
Atropine—Rash—Etoposide—testicular cancer	0.000823	0.000823	CcSEcCtD
Atropine—Dermatitis—Etoposide—testicular cancer	0.000822	0.000822	CcSEcCtD
Atropine—Headache—Etoposide—testicular cancer	0.000818	0.000818	CcSEcCtD
Atropine—Chest pain—Methotrexate—testicular cancer	0.000816	0.000816	CcSEcCtD
Atropine—Tension—Doxorubicin—testicular cancer	0.000814	0.000814	CcSEcCtD
Atropine—Dysgeusia—Doxorubicin—testicular cancer	0.000812	0.000812	CcSEcCtD
Atropine—Nervousness—Doxorubicin—testicular cancer	0.000806	0.000806	CcSEcCtD
Atropine—Vertigo—Epirubicin—testicular cancer	0.000806	0.000806	CcSEcCtD
Atropine—Syncope—Epirubicin—testicular cancer	0.000804	0.000804	CcSEcCtD
Atropine—Palpitations—Epirubicin—testicular cancer	0.000792	0.000792	CcSEcCtD
Atropine—Confusional state—Methotrexate—testicular cancer	0.000788	0.000788	CcSEcCtD
Atropine—Loss of consciousness—Epirubicin—testicular cancer	0.000788	0.000788	CcSEcCtD
Atropine—Anaphylactic shock—Methotrexate—testicular cancer	0.000782	0.000782	CcSEcCtD
Atropine—Vision blurred—Doxorubicin—testicular cancer	0.000782	0.000782	CcSEcCtD
Atropine—Convulsion—Epirubicin—testicular cancer	0.000777	0.000777	CcSEcCtD
Atropine—Nausea—Etoposide—testicular cancer	0.000775	0.000775	CcSEcCtD
Atropine—Chest pain—Epirubicin—testicular cancer	0.000763	0.000763	CcSEcCtD
Atropine—Agitation—Doxorubicin—testicular cancer	0.000762	0.000762	CcSEcCtD
Atropine—Anxiety—Epirubicin—testicular cancer	0.000761	0.000761	CcSEcCtD
Atropine—Hyperhidrosis—Methotrexate—testicular cancer	0.000756	0.000756	CcSEcCtD
Atropine—Dry mouth—Epirubicin—testicular cancer	0.000747	0.000747	CcSEcCtD
Atropine—Vertigo—Doxorubicin—testicular cancer	0.000745	0.000745	CcSEcCtD
Atropine—Syncope—Doxorubicin—testicular cancer	0.000744	0.000744	CcSEcCtD
Atropine—Confusional state—Epirubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Atropine—Palpitations—Doxorubicin—testicular cancer	0.000733	0.000733	CcSEcCtD
Atropine—Oedema—Epirubicin—testicular cancer	0.000732	0.000732	CcSEcCtD
Atropine—Anaphylactic shock—Epirubicin—testicular cancer	0.000732	0.000732	CcSEcCtD
Atropine—Hypotension—Methotrexate—testicular cancer	0.000731	0.000731	CcSEcCtD
Atropine—Loss of consciousness—Doxorubicin—testicular cancer	0.000729	0.000729	CcSEcCtD
Atropine—Shock—Epirubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Atropine—Convulsion—Doxorubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Atropine—Tachycardia—Epirubicin—testicular cancer	0.000714	0.000714	CcSEcCtD
Atropine—Hyperhidrosis—Epirubicin—testicular cancer	0.000707	0.000707	CcSEcCtD
Atropine—Insomnia—Methotrexate—testicular cancer	0.000707	0.000707	CcSEcCtD
Atropine—Chest pain—Doxorubicin—testicular cancer	0.000706	0.000706	CcSEcCtD
Atropine—Anxiety—Doxorubicin—testicular cancer	0.000704	0.000704	CcSEcCtD
Atropine—Dyspnoea—Methotrexate—testicular cancer	0.000697	0.000697	CcSEcCtD
Atropine—Somnolence—Methotrexate—testicular cancer	0.000695	0.000695	CcSEcCtD
Atropine—Dry mouth—Doxorubicin—testicular cancer	0.000691	0.000691	CcSEcCtD
Atropine—Dyspepsia—Methotrexate—testicular cancer	0.000688	0.000688	CcSEcCtD
Atropine—Hypotension—Epirubicin—testicular cancer	0.000684	0.000684	CcSEcCtD
Atropine—Confusional state—Doxorubicin—testicular cancer	0.000683	0.000683	CcSEcCtD
Atropine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Atropine—Oedema—Doxorubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Atropine—Fatigue—Methotrexate—testicular cancer	0.000674	0.000674	CcSEcCtD
Atropine—Pain—Methotrexate—testicular cancer	0.000669	0.000669	CcSEcCtD
Atropine—Shock—Doxorubicin—testicular cancer	0.000666	0.000666	CcSEcCtD
Atropine—Insomnia—Epirubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Atropine—Tachycardia—Doxorubicin—testicular cancer	0.000661	0.000661	CcSEcCtD
Atropine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000655	0.000655	CcSEcCtD
Atropine—Dyspnoea—Epirubicin—testicular cancer	0.000652	0.000652	CcSEcCtD
Atropine—Somnolence—Epirubicin—testicular cancer	0.000651	0.000651	CcSEcCtD
Atropine—Feeling abnormal—Methotrexate—testicular cancer	0.000644	0.000644	CcSEcCtD
Atropine—Dyspepsia—Epirubicin—testicular cancer	0.000644	0.000644	CcSEcCtD
Atropine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000639	0.000639	CcSEcCtD
Atropine—Hypotension—Doxorubicin—testicular cancer	0.000633	0.000633	CcSEcCtD
Atropine—Fatigue—Epirubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Atropine—Constipation—Epirubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Atropine—Pain—Epirubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Atropine—Urticaria—Methotrexate—testicular cancer	0.000621	0.000621	CcSEcCtD
Atropine—Abdominal pain—Methotrexate—testicular cancer	0.000618	0.000618	CcSEcCtD
Atropine—Body temperature increased—Methotrexate—testicular cancer	0.000618	0.000618	CcSEcCtD
Atropine—Insomnia—Doxorubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Atropine—Dyspnoea—Doxorubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Atropine—Feeling abnormal—Epirubicin—testicular cancer	0.000603	0.000603	CcSEcCtD
Atropine—Somnolence—Doxorubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Atropine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Atropine—Dyspepsia—Doxorubicin—testicular cancer	0.000596	0.000596	CcSEcCtD
Atropine—Fatigue—Doxorubicin—testicular cancer	0.000584	0.000584	CcSEcCtD
Atropine—Urticaria—Epirubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Atropine—Pain—Doxorubicin—testicular cancer	0.000579	0.000579	CcSEcCtD
Atropine—Constipation—Doxorubicin—testicular cancer	0.000579	0.000579	CcSEcCtD
Atropine—Body temperature increased—Epirubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Atropine—Abdominal pain—Epirubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Atropine—Hypersensitivity—Methotrexate—testicular cancer	0.000576	0.000576	CcSEcCtD
Atropine—Asthenia—Methotrexate—testicular cancer	0.000561	0.000561	CcSEcCtD
Atropine—Feeling abnormal—Doxorubicin—testicular cancer	0.000558	0.000558	CcSEcCtD
Atropine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000554	0.000554	CcSEcCtD
Atropine—Pruritus—Methotrexate—testicular cancer	0.000553	0.000553	CcSEcCtD
Atropine—Hypersensitivity—Epirubicin—testicular cancer	0.000539	0.000539	CcSEcCtD
Atropine—Urticaria—Doxorubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Atropine—Body temperature increased—Doxorubicin—testicular cancer	0.000535	0.000535	CcSEcCtD
Atropine—Abdominal pain—Doxorubicin—testicular cancer	0.000535	0.000535	CcSEcCtD
Atropine—Diarrhoea—Methotrexate—testicular cancer	0.000535	0.000535	CcSEcCtD
Atropine—Asthenia—Epirubicin—testicular cancer	0.000525	0.000525	CcSEcCtD
Atropine—Pruritus—Epirubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Atropine—Dizziness—Methotrexate—testicular cancer	0.000517	0.000517	CcSEcCtD
Atropine—Diarrhoea—Epirubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Atropine—Hypersensitivity—Doxorubicin—testicular cancer	0.000499	0.000499	CcSEcCtD
Atropine—Vomiting—Methotrexate—testicular cancer	0.000497	0.000497	CcSEcCtD
Atropine—Rash—Methotrexate—testicular cancer	0.000493	0.000493	CcSEcCtD
Atropine—Dermatitis—Methotrexate—testicular cancer	0.000493	0.000493	CcSEcCtD
Atropine—Headache—Methotrexate—testicular cancer	0.00049	0.00049	CcSEcCtD
Atropine—Asthenia—Doxorubicin—testicular cancer	0.000486	0.000486	CcSEcCtD
Atropine—Dizziness—Epirubicin—testicular cancer	0.000484	0.000484	CcSEcCtD
Atropine—Pruritus—Doxorubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
Atropine—Vomiting—Epirubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Atropine—Nausea—Methotrexate—testicular cancer	0.000464	0.000464	CcSEcCtD
Atropine—Diarrhoea—Doxorubicin—testicular cancer	0.000463	0.000463	CcSEcCtD
Atropine—Rash—Epirubicin—testicular cancer	0.000461	0.000461	CcSEcCtD
Atropine—Dermatitis—Epirubicin—testicular cancer	0.000461	0.000461	CcSEcCtD
Atropine—Headache—Epirubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Atropine—Dizziness—Doxorubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Atropine—Nausea—Epirubicin—testicular cancer	0.000435	0.000435	CcSEcCtD
Atropine—Vomiting—Doxorubicin—testicular cancer	0.000431	0.000431	CcSEcCtD
Atropine—Rash—Doxorubicin—testicular cancer	0.000427	0.000427	CcSEcCtD
Atropine—Dermatitis—Doxorubicin—testicular cancer	0.000427	0.000427	CcSEcCtD
Atropine—Headache—Doxorubicin—testicular cancer	0.000424	0.000424	CcSEcCtD
Atropine—Nausea—Doxorubicin—testicular cancer	0.000402	0.000402	CcSEcCtD
